Company intelligence / Profile preview

Vials RX

Tomball, Texas, United States

Ownership: Private

Overview

Vials RX is a technology-enabled 503A compounding pharmacy based in Tomball and Houston, Texas. The company specializes in personalized compounding formulations, primarily focusing on GLP-1 receptor agonists such as semaglutide and tirzepatide for weight management and anti-aging therapies. Vials RX leverages AI-driven systems to guide the compounding process, recommend patient-specific formulations to prescribing physicians, and optimize delivery workflows. The pharmacy partners with various telehealth platforms, including Piper, NativeMed, Framework, and Trimi, to deliver customized treatments directly to patients.

Modalities: PeptidesBiologicSmall molecule
Industry: Non-Academic Healthcare

Partnerships

PiperNativeMedFrameworkTrimiEverhuman LabsIdgie HealthElara

Beyond the preview

Go deeper on Vials RX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vials RX.

Explore the full profile